Furin as a therapeutic target in cystic fibrosis airways disease
Clinical management of cystic fibrosis (CF) has been greatly improved by the development of small molecule modulators of the CF transmembrane conductance regulator (CFTR). These drugs help to address some of the basic genetic defects of CFTR; however, no suitable CFTR modulators exist for 10% of peo...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2023-05-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/32/168/220256.full |